臓器保存液の世界市場

◆英語タイトル:Organ Preservation Solutions : Global Strategic Business Report
◆商品コード:GIA60279
◆発行会社(調査会社):Global Industry Analysts
◆発行日:2015年9月
◆ページ数:113
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:産業未分類
◆販売価格オプション(消費税別)
Single User(DRM付き)USD4,500 ⇒換算¥513,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご確認ください。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(支払期限と方法は調整可能、振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobal Industry Analysts社の日本における正規販売代理店です。Global Industry Analysts社の概要及び新刊レポートはこちらでご確認いただけます。
当調査レポートでは、臓器保存液の世界市場について調査・分析し、臓器保存液の世界市場規模、市場動向、市場予測、関連企業情報などをお届けいたします。
【レポートの概要】

This report analyzes the worldwide markets for Organ Preservation Solutions in US$ Thousand. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, and Rest of World. Annual estimates and forecasts are provided for the period 2014 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 21 companies including many key and niche players such as –
21st Century Medicine
BioLife Solutions, Inc.
Claris Injectables Limited
Dr. Franz Köhler Chemie GmbH
Essential Pharmaceuticals, LLC

【レポートの目次】

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS
Study Reliability and Reporting Limitations
Disclaimers
Data Interpretation & Reporting Level
Quantitative Techniques & Analytics
Product Definitions and Scope of Study
II. EXECUTIVE SUMMARY
1. INDUSTRY OVERVIEW
A Prelude
Current & Future Market Analysis
Geographic Landscape
Competitive Scenario
Table 1: Global Organ Preservation Solutions Market (2011 & 2015): Percentage Breakdown of Dollar Sales for Perfadex, Hypo Thermosol, Custodiol® HTK, Renograf, Viaspan, and Others (includes corresponding Graph/Chart)
Custodiol HTK Gains Prominence vs. the Gold Standard UW Solution
Contamination Concerns with Regard to ViaSpan®
Organ Preservation Techniques
Simple Cold Storage
Continuous Hypothermic Perfusion/Hypothermic Perfusion Preservation
2. MARKET TRENDS AND GROWTH DRIVERS
EVLP: Revolutionary Technique for Lung Preservation
New Paradigms in Heart and Lung Preservation
Organ Banking: Glimpse into the Future?
Preservation Solutions – A Key to Deceased Donor Transplants
Euro-Collins Extending Opportunities in the Kidney Segment
Cardiac Preservation Scenario Remains Static
Lungs Preservation in Search of Ideal Solution
Scientists See Cryopreservation as a Potential Means for Organ Preservation
Measures to Address Organ Shortage to Infuse Demand for Preservation Solutions
Europe and the United States Lead the Global Organ Transplants Market
Table 2: Global Organ Transplants by Leading Country in Terms of No. of Transplants Per Million Population (PMP) for the Year 2012 (includes corresponding Graph/Chart)
Living Donors on the Rise
Table 3: Global Living Organ Donors by Leading Country in Terms of No. of Donors Per Million Population (PMP) for the Year 2013 (includes corresponding Graph/Chart)
Table 4: Global Deceased Organ Donors by Leading Country in Terms of No. of Donors Per Million Population (PMP) for the Year 2013 (includes corresponding Graph/Chart)
Graying Population and Chronic Diseases Surge Need for Transplants
Table 5: Elderly Population (65+ Years) as a % of Total Population (2000 & 2025P) (includes corresponding Graph/Chart)
Transplant Tourism – Creating Brighter Avenues
Combined Organ Transplantation – Gaining Attention
Table 6: Multiple Organ Transplants in the US – No. of Transplants by Type (2010-2015)
Cardiac Arrest Death Patients – The Untapped Potential Donors
Table 7: Leading Countries in Terms of Number of Donors after Cardiac Death (DCD): 2013 (includes corresponding Graph/Chart)

3. PRODUCT OVERVIEW
Organ Preservation Solutions
Elements and Functions of Organ Preservation Solutions
Technical Specifications of the Organ Preservation Solutions
Solutions in Concentrated Form
Steps in Organ Preservation
Identification of the Donor
Organ Removal
Organ Recovery and Preservation
Organ Preservation Techniques
Hypothermia
Requirements of Ideal Preservation Solution
Factors Determining Organ Viability
Storage Duration Time
Storage Time Period for Organs and Tissues
Factors Impacting the Organ Preservation
Hypothermia Induced Cell Swelling
Cellular Acidosis and ATP Usage
Compromised Membrane Function
Functions of Organ Preservation Solutions
Prevention of Reactive Oxygen Species Formation
Reduction of Cell Swelling
Prevention of Cellular Acidosis
Benefits with Colloids
Secondary Functions
Production and Packaging
Production
Packaging
Tests for Organ Preservation Solutions
Hydroxymethylfurfural Test
Particulate Contamination
Test for Pyrogens
Static Cold Storage – The Most Applied and Popular Technique
Vitrification – A Promising Cryopreservation Approach for Whole Organs
Select Products
Euro Collins Solution
Composition of Euro-Collins Solution
University of Wisconsin (UW) Solution
Composition of UW Solution
Custodiol® Histidine-Tryptophan-Ketoglutarate (HTK) Solution
Composition of Custodial HTK Solution
Advantages
Disadvantages
Major Clinical Differences between Custodiol HTK and Viaspan
Celsior Solution
Composition of Celsior Solution
Hypothermosol
Perfadex®
Advantages
Ross-Marshall Citrate Solutions
Phosphate-Buffered Sucrose Solution
Lifor
HBS Solution
ET-Kyoto
Composition of ET-Kyoto Solution
Polysol
TranSend
Background
Organ Transplantation
A Prelude
Heart Transplantation
Heart Diseases and Disorders
Post-Operative Complications and Consequences of Heart Transplants
Kidney Transplantation
Kidney Disorders and Diseases
Donor Evaluation
Waiting List
Surgery/Post-Operation
Post-Operative Supervision and Issues
Liver Transplantation
Liver Disorders and Diseases
Pancreas Transplantation
Post-Operative Complications and Consequences of Pancreas Transplants
Small Intestine Transplantation
Intestine Disorders and Diseases
Heart-and-Lung Transplantation
Lung Transplantation
Lung Diseases and Disorders
Lung Patients Survival Statistics
Transplantation Immunology
Acute Cellular Rejection
Chronic Rejection
Post-Transplant Observations
Types of Donors
Alive Donors
Related Donors
Good Samaritans
Rewarded/Forced Donors
Deceased Donors
Directed / Allocated
Organs Transplanted by Type of Donor
Organ Donation and Eligibility Criteria
Factors Considered for Matching Recipients to Donor Organs
Testing
Blood Typing
Tissue Typing
Issues Impacting Transplantation Market
Scarcity of Donor Organs
Organ Rejection
Other Issues
Ethical Concerns and Bioethical Issues
Lack of Requisite Expertise
Transplantation – Safety Requirements
Waiting List
Active Waiting List Patients
Inactive Waiting List Patients
Transplantation Expenses
Major Medical and Non-Medical Expenses
Major Milestones in Organ Transplantation
4. RECENT INDUSTRY ACTIVITY
Paragonix Technologies Announces Publication of Sherpa Pak™ Transport Systems
CFDA Approves Organ Preservation Solutions by Lifeline Scientific
Provepharm Enters Into Partnership with DFKC
HEMARINA Signs Contract with LFB Biomanufacturing
HEMARINA Establishes Operations in the US
5. FOCUS ON SELECT KEY PLAYERS
21st Century Medicine (US)
BioLife Solutions, Inc. (US)
Claris Injectables Limited (India)
Dr. Franz Köhler Chemie GmbH (Germany)
Essential Pharmaceuticals, LLC (US)
Lifeline Scientific (US)
Preservation Solutions, Inc. (US)
XVIVO Perfusion AB (Sweden)
6. GLOBAL MARKET PERSPECTIVE
Table 8: World Recent Past, Current & Future Analysis for Organ Preservation Solutions by Geographic Region - US, Canada, Europe, Asia-Pacific, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 9: World Historic Review for Organ Preservation Solutions by Geographic Region - US, Canada, Europe, Asia-Pacific, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)
Table 10: World 14-Year Perspective for Organ Preservation Solutions by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Europe, Asia-Pacific, and Rest of World Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

III. MARKET
1. THE UNITED STATES
A. Market Analysis
Increasing Number of Organ Transplants Drives the Organ Preservation Market
Table 11: The US Kidney Transplants by Donor Type - Deceased and Living: Number of Procedures for 2013, 2014, and 2015 (As of Sept) (includes corresponding Graph/Chart)
Table 12: The US Liver Transplants by Donor Type - Deceased and Living: Number of Procedures for 2013, 2014, and 2015 (As of Sept, 2015) (includes corresponding Graph/Chart)
Table 13: The US Heart Transplants by Donor Type - Deceased and Living: Number of Procedures for 2013, 2014, and 2015 (As of Sept, 2015) (includes corresponding Graph/Chart)
Table 14: The US Lung Transplants by Donor Type - Deceased and Living: Number of Procedures for 2013, 2014, and 2015 (As of Sept, 2015) (includes corresponding Graph/Chart)
Table 15: The US Pancreas Transplants by Donor Type - Deceased and Living: Number of Procedures for 2013, 2014, and 2015 (As of Sept, 2015) (includes corresponding Graph/Chart)
Table 16: The US Intestinal Transplants by Donor Type - Deceased and Living: Number of Procedures for 2013, 2014, and 2015 (As of Sept, 2015) (includes corresponding Graph/Chart)
Ever-Increasing Waiting Lists Create Demand for Proper Organ Preservation
Table 17: The US Waiting List of Patients for Organ Transplants by Organ Type: As of September 2015 (includes corresponding Graph/Chart)
Strategic Corporate Developments
Select Key Players
B. Market Analytics
Table 18: The US Recent Past, Current & Future Analysis for Organ Preservation Solutions Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 19: The US Historic Review for Organ Preservation Solutions Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)
2. CANADA
Market Analysis
Table 20: Canadian Recent Past, Current & Future Analysis for Organ Preservation Solutions Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 21: Canadian Historic Review for Organ Preservation Solutions Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)
3. EUROPE
A. Market Analysis
Current & Future Analysis
Table 22: European Deceased Organ Donation Rates Per Million Population (PMP) by Country for 2011, 2012 & 2013 (includes corresponding Graph/Chart)
Table 23: European Living Organ Donation Rates Per Million Population (PMP) by Country for 2013 (includes corresponding Graph/Chart)
Table 24: European Single Organ Transplantations by Select Country and Organ Type: 2013 (includes corresponding Graph/Chart)
Table 25: European Multi-Organ Transplantations by Select Country and Transplant Type: 2013 (includes corresponding Graph/Chart)
Select Countries
Italy
The United Kingdom
Table 26: The UK Organ Donors by Type: May 2015 & May 2014 (includes corresponding Graph/Chart)
Table 27: The UK Organ Transplantation by Type: 2014 Vs. 2015 (includes corresponding Graph/Chart)
Table 28: The UK Active Transplant Waiting List by Organ: As of April 2014 and April 2015 (includes corresponding Graph/Chart)
Strategic Corporate Developments
Select Key Players
B. Market Analytics
Table 29: European Recent Past, Current & Future Analysis for Organ Preservation Solutions Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 30: European Historic Review for Organ Preservation Solutions Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)
4. ASIA-PACIFIC
A. Market Analysis
Select Regional Markets
Australia
Table 31: Australia Organ Transplantations by Organ Type: 2015 (includes corresponding Graph/Chart)
Table 32: Australian Organ Transplants by State: 2015 (includes corresponding Graph/Chart)
China
Cost Efficiency Lures Transplant Patients from Overseas
India
Overview of Renal Transplantation
Low Transplantation Expenses Boost Medical Tourism
Singapore
Awareness Programs to Increase Living Kidney Donations in Singapore
Strategic Corporate Development
Claris Injectables Limited (India) – A Key Player
B. Market Analytics
Table 33: Asia-Pacific Recent Past, Current & Future Analysis for Organ Preservation Solutions Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 34: Asia-Pacific Historic Review for Organ Preservation Solutions Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)
5. REST OF WORLD
A. Market Analysis
Current & Future Analysis
Select Regional Markets
Latin America
Brazil – A Major Transplant Market
The Middle East
Kuwait – A Rapidly Emerging ‘Third World’ Country in Organ Transplants
Iran – “Kidney E-Bay”
B. Market Analytics
Table 35: Rest of World Recent Past, Current & Future Analysis for Organ Preservation Solutions Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 36: Rest of World Historic Review for Organ Preservation Solutions Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)
IV. COMPETITIVE LANDSCAPE
Total Companies Profiled: 21
The United States (13)
Europe (7)
- France (2)
- Germany (1)
- The United Kingdom (1)
- Rest of Europe (3)
Asia-Pacific (Excluding Japan) (1)

★調査レポート[臓器保存液の世界市場]販売に関する免責事項
★調査レポート[臓器保存液の世界市場]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆